Dengue cases as per WHO classification (2009) Child,
Conditions
Interventions
Children in treatment group will be given chelated zinc in form of zinc bis-
glycinate (15 mg elemental zinc) 3 times a day for 5 days or until convalescence of fever.,Children in placebo group will receive ORS based placebo which is prepared by the same manufacturer and is in
Sponsors
Srinakharinwirot University
Srinakharinwirot University
Eligibility
Sex/Gender
All
Age
1 Years to 15 Years
Inclusion criteria
Inclusion criteria: children with fever and 2 of the following criteria: 1) nausea, vomiting 2) rash 3) aches and pain 4) Touniquet test positive 5) Leukopenia 6) any warning sign (adbominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy or restlessness, liver enlargment >2 cm, increase in HCT concurrent with rapid decrease in platelet count
Exclusion criteria
Exclusion criteria: children already taking vitamin or minerals regularly or having allergy to them will be excluded. Children with known history of chronic systemic illness will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recovery time at the end of study day of covalescence of fever | — |
Secondary
| Measure | Time frame |
|---|---|
| plasma zinc levels 72 hours direct mesure of plasma zinc | — |
Countries
Thailand
Contacts
Public ContactSanguansak Rerksuppaphol
Srinakharinwirot University
Outcome results
None listed